Actinium Pharmaceuticals
ATNM
#9862
Rank
C$60.48 M
Marketcap
C$1.94
Share price
-2.10%
Change (1 day)
3.83%
Change (1 year)

Actinium Pharmaceuticals (ATNM) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : C$60.94 Million

According to Actinium Pharmaceuticals's latest financial reports the company's total liabilities are C$60.94 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Actinium Pharmaceuticals - Total liabilities on balance sheet (from 2006 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$63.34 M5.97%
2023-12-31C$59.77 M-7.67%
2022-12-31C$64.74 M642.36%
2021-12-31C$8.72 M34.69%
2020-12-31C$6.47 M-17.73%
2019-12-31C$7.87 M-4.92%
2018-12-31C$8.27 M41.1%
2017-12-31C$5.86 M-3.43%
2016-12-31C$6.07 M-5.08%
2015-12-31C$6.39 M-41.9%
2014-12-31C$11.01 M41.26%
2013-12-31C$7.79 M68.88%
2012-12-31C$4.61 M-12.85%
2011-12-31C$5.29 M5492.81%
2010-12-31C$0.09 M-8.52%
2009-12-31C$0.1 M11.79%
2008-12-31C$0.09 M106.18%
2007-12-31C$0.04 M104.48%
2006-12-31C$0.02 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Genocea Biosciences
GNCA
C$36.56 M-40.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$2.15 B 3,440.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C$0.88 B 1,350.75%๐Ÿ‡บ๐Ÿ‡ธ USA